ES2104966T3 - 2,5-diamino-4,6-dicloropirimidinas protegidas en n-5 y procedimiento para su preparacion. - Google Patents

2,5-diamino-4,6-dicloropirimidinas protegidas en n-5 y procedimiento para su preparacion.

Info

Publication number
ES2104966T3
ES2104966T3 ES93100883T ES93100883T ES2104966T3 ES 2104966 T3 ES2104966 T3 ES 2104966T3 ES 93100883 T ES93100883 T ES 93100883T ES 93100883 T ES93100883 T ES 93100883T ES 2104966 T3 ES2104966 T3 ES 2104966T3
Authority
ES
Spain
Prior art keywords
diamino
protected
dichloropirimidinas
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93100883T
Other languages
English (en)
Inventor
Gerhard Dr Stucky
Felix Dr Previdoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lonza AG
Original Assignee
Lonza AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza AG filed Critical Lonza AG
Application granted granted Critical
Publication of ES2104966T3 publication Critical patent/ES2104966T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Abstract

2,5 O, DE FORMULA GENERAL, SON PRODUCTOS INTERMEDIOS VALIOSOS PARA LA OBTENCION DE MEDICAMENTOS CON PROPIEDADES ANTIVIRALES. LOS COMPUESTOS NOMBRADOS SON OBTENIDOS POR CICLIZACION DE UN ESTER DEL ACIDO AMINOMALONICO CON N PROTEGIDO CON GUANIDINA, EN PRESENCIA DE UN ALCOHOLATO ALCALINO, Y LA CLORACION POSTERIOR DE LA 4,6 DIHIDROXI ULTANTE.
ES93100883T 1992-01-22 1993-01-21 2,5-diamino-4,6-dicloropirimidinas protegidas en n-5 y procedimiento para su preparacion. Expired - Lifetime ES2104966T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH17992 1992-01-22

Publications (1)

Publication Number Publication Date
ES2104966T3 true ES2104966T3 (es) 1997-10-16

Family

ID=4181070

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93100883T Expired - Lifetime ES2104966T3 (es) 1992-01-22 1993-01-21 2,5-diamino-4,6-dicloropirimidinas protegidas en n-5 y procedimiento para su preparacion.

Country Status (19)

Country Link
US (1) US5294710A (es)
EP (1) EP0552758B1 (es)
JP (1) JP3252502B2 (es)
KR (1) KR100262283B1 (es)
CN (1) CN1077193A (es)
AT (1) ATE154346T1 (es)
AU (1) AU658965B2 (es)
CA (1) CA2087880C (es)
CZ (1) CZ287049B6 (es)
DE (1) DE59306703D1 (es)
DK (1) DK0552758T3 (es)
ES (1) ES2104966T3 (es)
FI (1) FI930238A (es)
HU (1) HU219231B (es)
IL (2) IL104478A (es)
MX (1) MX9300267A (es)
PL (2) PL171743B1 (es)
SK (1) SK279618B6 (es)
ZA (1) ZA93431B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9402161D0 (en) * 1994-02-04 1994-03-30 Wellcome Found Chloropyrimidine intermediates
CA2145928C (en) * 1994-04-27 2007-10-09 Gerhard Stucky N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide, and a process for its preparation
EP1188750B1 (de) * 1998-12-21 2003-10-15 Lonza AG Verfahren zur Herstellung von 2,5-Diamino-4,6-dihalogenpyrimidinen
US6608199B2 (en) * 2000-07-07 2003-08-19 Syngenta Limited Synthesis of chlorinated pyrimidines
CN102702110A (zh) * 2012-05-24 2012-10-03 盛世泰科生物医药技术(苏州)有限公司 一种4-氨基-5,6-二氯嘧啶的制备方法
CN103936681B (zh) * 2014-04-04 2015-07-29 苏州开元民生科技股份有限公司 2-氨基-4,6-二氯-5-甲酰胺基嘧啶的制备方法
CN117050024B (zh) * 2023-10-13 2024-01-05 苏州开元民生科技股份有限公司 一种2-氨基-4,6-二氯-5-甲酰胺基嘧啶的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649291A5 (de) * 1982-03-16 1985-05-15 Hoffmann La Roche Dicarbamate.
GB8916698D0 (en) * 1989-07-21 1989-09-06 Beecham Group Plc Novel process

Also Published As

Publication number Publication date
IL104478A0 (en) 1993-05-13
EP0552758A1 (de) 1993-07-28
ZA93431B (en) 1993-08-25
AU658965B2 (en) 1995-05-04
HUT63618A (en) 1993-09-28
FI930238A (fi) 1993-07-23
JPH05279344A (ja) 1993-10-26
CA2087880A1 (en) 1993-07-23
ATE154346T1 (de) 1997-06-15
SK393192A3 (en) 1995-09-13
IL119700A0 (en) 1997-02-18
KR930016404A (ko) 1993-08-26
JP3252502B2 (ja) 2002-02-04
MX9300267A (es) 1993-11-01
PL171743B1 (pl) 1997-06-30
FI930238A0 (fi) 1993-01-21
KR100262283B1 (ko) 2000-08-01
CZ393192A3 (en) 1993-08-11
SK279618B6 (sk) 1999-01-11
EP0552758B1 (de) 1997-06-11
AU3200193A (en) 1993-07-29
PL171137B1 (pl) 1997-03-28
US5294710A (en) 1994-03-15
CA2087880C (en) 2004-06-15
CZ287049B6 (cs) 2000-08-16
HU9300182D0 (en) 1993-04-28
DK0552758T3 (da) 1997-07-07
CN1077193A (zh) 1993-10-13
IL104478A (en) 1997-06-10
HU219231B (en) 2001-03-28
DE59306703D1 (de) 1997-07-17
PL297517A1 (en) 1993-08-23

Similar Documents

Publication Publication Date Title
DE69811867T2 (de) Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten
DE69128321D1 (de) Polysiloxanderivat, dessen Verwendung als Emulgator und kosmetische Präparationen
AR023777A1 (es) Nuevos compuestos
NO970042L (no) 2-£(Dihydro)pyrazolyl-3'-oksymetylen|-anilider, fremgangsmåte til fremstilling og anvendelse derav
IL126610A0 (en) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3- one derivatives as factor xa inhibitors
DE69101922T2 (de) Verwendung von pyrimidin-3-oxydderivaten zur verhütung von haarausfall und deren anwendung in topischen zusammensetzungen.
DK0425650T3 (da) Antiinflammatoriske 4-aminophenolderivater
DE69316910T2 (de) Neue vitamin d derivate
DE3774858D1 (de) Derivate von n-(2-alkyl-3-mercaptoglutaryl)-alpha-aminosaeuren und deren verwendung als collagenase-inhibitoren.
CO4761058A1 (es) Nuevos derivados de benzoilguanidina, procedimientos para su preparacion y su utilizacion en la preparacion de medicamentos
ES2104966T3 (es) 2,5-diamino-4,6-dicloropirimidinas protegidas en n-5 y procedimiento para su preparacion.
ATE229034T1 (de) 3-mercaptoacetylamino-1,5-substituierte-2-oxo- azepan derivate und deren verwendung als inhibitoren von matrix-metalloproteinasen
MX9100560A (es) Integron de corinebacterias,procedimiento para la transformacion corinebacteria mediante dicho integron y corinebacteria obtenida
MX9206482A (es) 1,5-pentanodioles substituidos y procesos para la preparacion de los mismos
ITBZ950045A0 (it) Gioiello e procedimento per la realizzazione dello stesso.
FI934468A0 (fi) Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytesmellanprodukter
NO985550D0 (no) FremgangsmÕte for fremstilling av 2,2'-(1-metyl-1,2-etandiyliden)bis(hydrazinkarboksimidamid)
FI972673A (fi) 4,4-(disubstituoitu)sykloheksan-1-oli-monomeereja ja vastaavia yhdisteitä
DK0730861T3 (da) Anvendelse af 6,7-substituerede 2-aminotetraliner til fremstilling af farmaceutiske præparater, der er nyttige til behandli
MX9307736A (es) Nuevas triazoloquinazolinas, su obtencion y uso.
MX24595A (es) Derivados de fenilimidazol y procedimiento para supreparacion.
AR012449A1 (es) Kodaistatinas a, b, c y d, proceso para su produccion, y su uso.
MX9102649A (es) 2,6-dialquilanilinas,4-substituidas y procedimiento para su preparacion.
BR9710170A (pt) Processo de preparação de 2,2'-(1-metil-1,2-etano-dilideno)bis(hidrazina carboximido)
IT8919343A0 (it) Nastro e procedimento per l'arricciamento di tendaggi.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 552758

Country of ref document: ES